Heron Therapeutics Inc (HRTX)

4.925 +0.06 (+1.13%) USD  |  NASDAQ  |  Aug 12, 10:09
More

Heron Therapeutics News

News

Headline
Wire
Time (ET)
Heron Shares Jump After Equity Financing, Q2 Earnings
Yahoo
08/09 14:10
Heron Therapeutics Q2 Loss Narrows as Revenue Increases; Shares Rise
MT Newswires
08/09 12:23
Heron Therapeutics Launches $76.5 Million Private Placement; Shares Rise
MT Newswires
08/09 10:59
Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates
Yahoo
08/09 09:15
Heron Therapeutics Announces $76.5 Million Private Placement Financing
PR Newswire
08/09 08:01
Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Highlights Recent Corporate Updates
PR Newswire
08/09 08:00
Notable earnings before Tuesday's open
SA Breaking News
08/08 10:46
Heron Therapeutics to Report Second Quarter 2022 Financial Results on Tuesday, August 9, 2022
PR Newswire
08/02 16:05
Heron Therapeutics (NASDAQ:HRTX) shareholders have endured a 83% loss from investing in the stock three years ago
Yahoo
07/21 06:32
7 Biotech Stocks to Buy for Q3
Yahoo
07/18 18:00
Heron Therapeutics to Cut Workforce by 34% Under Restructuring Plan
MT Newswires
06/30 09:25
Heron Therapeutics to cut about one-third of its workforce as part of cost-cutting plan
Yahoo
06/30 08:41
Heron Therapeutics Announces Restructuring and Cost Reduction Plan to Address Market Dynamics and Prepare for Long-Term Sustainability
PR Newswire
06/30 08:30
Heron Therapeutics Announces Publication Showing ZYNRELEF® as the Foundation of a Perioperative Non-Opioid Multimodal Analgesic Regimen Reduced Severe Pain and Opioid Use in Patients Undergoing Total Knee Arthroplasty
Yahoo
06/14 08:30
Heron Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference
PR Newswire
05/26 16:05
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Heron Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
PR Newswire
05/26 07:30
Heron Therapeutics Presents ZYNRELEF® Data at the Society for Obstetric Anesthesia and Perinatology 54th Annual Meeting
PR Newswire
05/16 16:05
--Cantor Fitzgerald Adjusts Price Target for Heron Therapeutics to $12 From $20, Maintains Overweight Rating
MT Newswires
05/10 14:10
Needham Adjusts Heron Therapeutics' Price Target to $14 from $16, Keeps Buy Rating
MT Newswires
05/10 09:06
Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates
PR Newswire
05/09 16:05
Notable earnings after Monday's close
SA Breaking News
05/08 17:35
Heron Therapeutics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
PR Newswire
05/03 16:05
Cantor lists pharma stocks with notable changes in short interest
SA Breaking News
04/12 15:25
Heron Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference
PR Newswire
04/05 16:05
Heron Therapeutics Says Zynrelef Gets Pass-Through Payment Status From Centers for Medicare & Medicaid Services
MT Newswires
03/25 09:34
Heron Therapeutics Secures Pass-through Payment Status for ZYNRELEF® from Centers for Medicare & Medicaid Services, Expanding Separate Reimbursement into the Hospital Outpatient Setting of Care
PR Newswire
03/25 08:30
Heron Therapeutics Announces Approval of ZYNRELEF® by Health Canada for the Management of Postoperative Pain
PR Newswire
03/17 08:30
Heron Therapeutics to Present at 42nd Annual Cowen Healthcare Conference
PR Newswire
03/02 16:05
Heron Therapeutics Q4 Loss Narrows, Revenue Edges Higher; Shares Plummet Tuesday Afternoon
MT Newswires
03/01 14:40
NVEE and IMPP among mid-day movers
SA Breaking News
03/01 12:47
--Needham & Co Adjusts Heron Therapeutics Price Target to $16 From $24, Maintains Buy Rating
MT Newswires
03/01 11:14
--Cowen & Co Adjusts Heron Therapeutics Price Target to $13 From $31, Maintains Outperform Rating
MT Newswires
03/01 11:14
Heron stock falls 21% as Q4 sales remain largely flat Y/Y
SA Breaking News
03/01 10:38
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Recent Corporate Updates
PR Newswire
02/28 16:05
Notable earnings after Monday's close
SA Breaking News
02/27 17:35
Heron Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on Monday, February 28, 2022
PR Newswire
02/22 16:05
Heron Therapeutics Obtains FDA Approval for Expanded Indication of Zynrelef
MT Newswires
12/09 09:38
Heron Therapeutics Announces FDA Approval of a Significant Indication Expansion for ZYNRELEF®
PR Newswire
12/09 08:00
Heron Therapeutics Files New-Drug Application for HTX-019 With FDA; Shares Up Pre-Bell
MT Newswires
11/18 09:32
Heron Therapeutics to Present at Upcoming Investor Conferences
PR Newswire
11/11 16:05
Heron Therapeutics Reports FDA Submission for Expanded Use of Local Anesthetic Zynrelef
MT Newswires
10/04 11:29
Heron Therapeutics Announces Filing of a Supplemental New Drug Application for Significant Expansion of ZYNRELEF® Indication Statement Based on Successful Outcome of FDA Type C Meeting
PR Newswire
10/04 08:30
Heron Therapeutics to Present at the 2021 Cantor Virtual Global Healthcare Conference
PR Newswire
09/21 16:05
Heron Therapeutics Q2 Loss Widens by a Penny, Revenue Declines; Shares Dip
MT Newswires
08/09 09:36
Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Recent Corporate Updates
PR Newswire
08/09 08:00
Heron Therapeutics Announces Publication of Results from HOPE (Helping Opioid Prescription Elimination), Showing ZYNRELEF™ Minimizes the Need for Opioids in a Real-World Setting, With 95% of Patients Experiencing an Opioid-free Recovery
PR Newswire
07/28 16:05
Heron Therapeutics highlights promising data from ZYNRELEF postoperative pain trials
SA Breaking News
07/21 16:29
Heron Therapeutics Announces Publication Showing Reduction of Pain and Opioid Use Compared to Bupivacaine in Patients 65 and Older with ZYNRELEF™
PR Newswire
07/21 16:05
Heron Therapeutics Announces 340B Prime Vendor Contract with Apexus for ZYNRELEF™
PR Newswire
07/06 08:30
Heron Therapeutics launches ZYNRELEF in the U.S.
SA Breaking News
07/01 09:09
Heron Therapeutics Announces U.S. Commercial Launch and Availability of ZYNRELEF™ for the Management of Postoperative Pain for up to 72 Hours
PR Newswire
07/01 08:30
Heron Therapeutics files for 12.4M common stock offering from shareholder
SA Breaking News
05/28 17:02
Heron Therapeutics to Present at the 2021 Jefferies Virtual Investor Conference
PR Newswire
05/25 16:05
Heron Therapeutics Sells $150 Million in Convertible Notes Due 2026 to Fund Launch of Extended-Release Local Anesthetic
MT Newswires
05/25 14:24
Heron Therapeutics completes $150 million convertible debt financing
SA Breaking News
05/25 09:43
Thinking about buying stock in Heron Therapeutics, Casper Sleep, Evolus, Xeris Pharmaceuticals, or Atara Biotherapeutics?
PR Newswire
05/13 09:31
Heron Therapeutics Says FDA Approves Zynrelef for Post-Operative Pain
MT Newswires
05/13 09:09
Heron Therapeutics surges on FDA approval for ZYNRELEF
SA Breaking News
05/13 08:25
AMC, OCGN, SONO and HRTX among premarket gainers
SA Breaking News
05/13 08:23
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
PR Newswire
05/13 08:00
Heron Therapeutics climbs on management comments on upcoming milestone
SA Breaking News
05/10 10:51
Heron Therapeutics Q1 Loss Expands as Revenue Decreases
MT Newswires
05/10 09:10
Heron Therapeutics EPS misses by $0.03, misses on revenue
SA Breaking News
05/10 08:44
Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Recent Corporate Updates
PR Newswire
05/10 08:30
Seeking Alpha Catalyst Watch
SA Breaking News
05/07 15:30
Thinking about buying stock in Phunware, Broadwind, Seelos Therapeutics, Golden Nugget Online Gaming, or Heron Therapeutics?
PR Newswire
04/06 09:31
Most-shorted U.S. stocks fall after rise earlier this year on GameStop squeeze
SA Breaking News
04/03 22:36
Heron Therapeutics EPS misses by $0.03, beats on revenue
SA Breaking News
02/24 08:57
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020 and Highlights Recent Corporate Updates
PR Newswire
02/24 08:30
Heron Therapeutics to Present at Several Upcoming Virtual Investor Conferences
PR Newswire
02/17 16:05
Heron's HTX-011 long term data published in a medical journal
SA Breaking News
01/21 12:19
Pacira BioSciences sheds 7% after SVB Leerink downgrade
SA Breaking News
01/21 12:17
Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery
PR Newswire
01/21 08:30
Heron Therapeutics Posts Preliminary Q4 Product Sales of $20.3 Million for Chemotherapy-Induced Nausea, Vomiting Franchises
MT Newswires
01/11 11:19
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
PR Newswire
01/11 08:30
Analyst Actions: Stifel Adjusts Heron Therapeutics' Price Target to $25 from $20, Keeps Buy Rating
MT Newswires
01/05 11:46
Analyst Actions: SVB Leerink Adjusts Heron Therapeutics' Price Target to $24 From $21, Keeps at Outperform
MT Newswires
12/02 09:49
Heron Therapeutics Resubmits New Drug Application for HTX-011 for the Treatment of Postoperative Pain
MT Newswires
11/13 09:09
Heron Therapeutics resubmits US application for HTX-011 in postop pain
SA Breaking News
11/13 09:06
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Treatment of Postoperative Pain
PR Newswire
11/13 08:30
Heron Therapeutics to Present at Several Upcoming Virtual Investor Conferences
PR Newswire
11/11 16:05
Heron Therapeutics EPS misses by $0.01, beats on revenue
SA Breaking News
11/05 08:37
-- Earnings Flash (HRTX) HERON THERAPEUTICS Posts Q3 Revenue $20M
MT Newswires
11/05 08:32
Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2020 and Highlights Recent Corporate Updates
PR Newswire
11/05 08:30
Heron's Zynrelef OK'd in Europe for post-op pain
SA Breaking News
09/28 09:39
Heron Therapeutics Gets European Commission's Authorization for Postoperative Pain Drug
MT Newswires
09/28 09:25
Heron Therapeutics Receives European Commission Authorization for ZYNRELEF™ (HTX-011) for the Treatment of Postoperative Pain
PR Newswire
09/28 08:30
Heron Therapeutics' HTX-011 shows positive action in herniorrhaphy
SA Breaking News
09/16 08:57
Heron Therapeutics Announces Publication of Results from EPOCH 2 Follow-On Study, a Phase 2b Study of HTX-011 in Patients Undergoing Hernia Repair Surgery
PR Newswire
09/16 08:30
Heron Therapeutics to Present at Cantor Virtual Global Healthcare Conference
PR Newswire
09/11 16:05
Heron Concludes Meeting With FDA Over Application for HTX-011 for Post-Operative Pain Management; Shares Up
MT Newswires
09/08 11:12
Heron Therapeutics has a successful outcome of FDA Type A meeting for HTX-011
SA Breaking News
09/08 09:28
Heron Therapeutics Announces Successful Outcome of FDA Type A Meeting to Discuss HTX-011 for the Management of Postoperative Pain
PR Newswire
09/08 08:30
Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2020 and Highlights Recent Corporate Updates
PR Newswire
08/05 16:05
European advisory group backs Heron drug for post-op pain
SA Breaking News
07/24 09:23
Heron Therapeutics Gets Positive European Opinion for Zynrelef for Post-Surgery Pain
MT Newswires
07/24 09:05
Heron Therapeutics Receives Positive CHMP Opinion for ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain
PR Newswire
07/24 08:30
Evercore ISI resumes best small/mid-cap ideas with 19 new names
SA Breaking News
07/20 18:49
Heron Shares Rise Pre-Bell After Starting Mid-Stage Study of Cinvanti for Early Hospitalized COVID-19 Patients
MT Newswires
07/16 09:01
Heron launches mid-stage study of aprepitant for COVID-19
SA Breaking News
07/16 08:44
Heron Therapeutics Announces Initiation of Phase 2 Clinical Study of CINVANTI® for the Treatment of COVID-19
PR Newswire
07/16 08:30
Heron Therapeutics readies mid-stage study of aprepitant for COVID-19
SA Breaking News
07/14 13:07
ICPT, WKHS, HRTX and BLNK among midday movers
SA Breaking News
06/29 12:41
Healthcare - Top 5 Gainers / Losers
SA Breaking News
06/29 11:06
Stocks Mixed in Early US Trading as Boeing Bolsters Dow While Tech Declines Dent Nasdaq
MT Newswires
06/29 10:01
US FDA Seeks Additional Information From Heron Therapeutics for Post-Operative Pain Management Drug; Shares Sink
MT Newswires
06/29 09:37
FDA rejects Heron Therapeutics' NDA for HTX-011 for postoperative pain
SA Breaking News
06/29 09:10
Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain
PR Newswire
06/29 08:45
Healthcare names lead premarket losers
SA Breaking News
06/29 08:09
INO, DVAX among premarket gainers
SA Breaking News
06/26 08:21
Heron's HTX-011 shows benefit in mid-stage knee replacement study
SA Breaking News
06/04 09:52
Heron Therapeutics Announces Publication of Results from Study 209, a Phase 2b Study of HTX-011 in Patients Undergoing Total Knee Arthroplasty
PR Newswire
06/04 09:00
Analyst Actions: Guggenheim Starts Heron Therapeutics at Buy With $24 Price Target
MT Newswires
05/27 09:28
Heron launches study of HTX-034 for postop pain
SA Breaking News
05/18 11:37
Heron Therapeutics Commences Clinical Trial of Post-Operative Pain Medication
MT Newswires
05/18 09:32
Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
PR Newswire
05/18 09:00
Heron Therapeutics Q1 Loss Narrows, Revenue Declines
MT Newswires
05/06 12:18
Heron Therapeutics EPS beats by $0.08, beats on revenue
SA Breaking News
05/06 10:08
Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2020 and Highlights Recent Corporate Updates
PR Newswire
05/06 09:00
Heron Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference
PR Newswire
04/09 16:05
FDA accepts Innocoll application for post-surgical pain implant
SA Breaking News
03/26 13:10
Key events next week - healthcare
SA Breaking News
03/20 11:23
Heron Therapeutics Slips After Posting Worse-Than-Expected Q4 Loss Per Share; Revenue Tops Consensus
MT Newswires
03/02 14:28
Heron Therapeutics EPS misses by $0.09, beats on revenue
SA Breaking News
03/02 07:39
Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2019 and Highlights Recent Corporate Updates
PR Newswire
03/02 07:30
Heron Therapeutics to Present at the 40th Annual Cowen Healthcare Conference
PR Newswire
02/25 16:05
Heron Therapeutics Down 4% After FDA Extends Review Period for HTX-011 Non-Opioid Pain Medication
MT Newswires
02/20 13:57
Analyst Actions: Needham & Co Cuts Heron Therapeutics Price Target to $48 From $50, Maintains Buy Rating
MT Newswires
02/20 11:13
Heron Therapeutics Announces FDA Extension of Review Period for NDA for HTX-011 for the Management of Postoperative Pain
PR Newswire
02/19 16:05
Heron Therapeutics to Present at the 9th Annual SVB Leerink Global Healthcare Conference
PR Newswire
02/18 16:05
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises
PR Newswire
01/13 08:30
Heron Therapeutics Announces Publication of the Mechanism of Action Data for HTX-011, a Dual-Acting Local Anesthetic Being Developed for Management of Postoperative Pain
PR Newswire
12/16 16:05
Heron Therapeutics Says Drug for Postoperative Pain Receives Priority Review Status From Health Canada
MT Newswires
12/03 09:11
Heron's HTX-011 nabs accelerated review in Canada for management of postoperative pain
SA Breaking News
12/03 07:45
Health Canada Grants Priority Review Status for Heron Therapeutics' New Drug Submission for HTX-011 for Management of Postoperative Pain
PR Newswire
12/03 07:30
Heron Therapeutics to Present at the Evercore ISI HealthCONx Conference
PR Newswire
11/26 16:05
Heron Therapeutics to Present at the Jefferies London Healthcare Conference
PR Newswire
11/14 16:05
Heron Therapeutics to Present at the Stifel 2019 Healthcare Conference
PR Newswire
11/13 16:05
Heron Therapeutics Climbs After Q3 Results Beat Estimates, FDA Accepts Resubmission of Pain Treatment NDA
MT Newswires
11/12 13:25
Heron Therapeutics EPS beats by $0.15, beats on revenue
SA Breaking News
11/12 08:33
Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2019 and Highlights Recent Corporate Updates
PR Newswire
11/12 08:30
FDA accepts Heron's refiled HTX-011 application; shares up 6% premarket
SA Breaking News
10/28 09:11
Heron Therapeutics Receives FDA Acceptance for New Drug Application Resubmission for HTX-011
MT Newswires
10/28 08:56
Heron Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for HTX-011 for Management of Postoperative Pain
PR Newswire
10/28 08:30
Heron Therapeutics' Cinvanti Receives Approval for Supplemental New Drug Application
MT Newswires
10/22 10:14
FDA OKs expanded label for Heron's Cinvanti, shares ahead 4% premarket
SA Breaking News
10/22 09:04
Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for Single-Dose Regimen for Patients Receiving Moderately Emetogenic Chemotherapy (MEC)
PR Newswire
10/22 08:30
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Healthcare Services Group, Heron Therapeutics, Immunomedics, and Karyopharm and Encourages Investors to Contact the Firm
Globe Newswire
10/04 22:00
Healthcare - Top 5 Gainers / Losers
SA Breaking News
10/04 11:01
Sector Update: Health Care Giants Mixed Pre-Market Friday
MT Newswires
10/04 09:21
Wall Street Set for Positive Open as US Jobless Rate Falls to 50-Year Low
MT Newswires
10/04 09:19
HPQ, HRTX among premarket losers
SA Breaking News
10/04 09:12
Heron Therapeutics (HRTX) Prices Common Stock Offering at $17.5/Share
MT Newswires
10/04 05:00
Heron Therapeutics prices equity offering
SA Breaking News
10/04 00:07
Heron Therapeutics Announces Pricing of Public Offering of Common Stock
PR Newswire
10/03 22:37
MT Newswires After-Hours News Movers
MT Newswires
10/03 17:40
Heron Therapeutics -4.5% on share offering
SA Breaking News
10/03 16:24
Heron Therapeutics Plans to Sell Shares - Stock Drops 4% After-Hours
MT Newswires
10/03 16:05
Heron Therapeutics Announces Proposed Public Offering of Common Stock
PR Newswire
10/03 16:01
Analyst Actions: JMP Securities Cuts Heron Therapeutics' Price Target to $32 From $38, Maintains Market Outperform Rating
MT Newswires
10/03 12:04
Sector Update: Health Care Stocks Benefit from Afternoon Bargain Hunting
MT Newswires
10/02 16:02
Sector Update: Health Care Stocks Retreat Wednesday
MT Newswires
10/02 14:17
Sector Update: Top Health Care Stocks Flat to Higher Pre-Market Wednesday
MT Newswires
10/02 09:13
Heron Study of Non-Opioid Painkiller Shows Pain Remained Mild 72 Hours After Surgery
MT Newswires
10/02 08:06
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
PR Newswire
10/02 07:45
Heron Therapeutics Appoints Kimberly Manhard to Board of Directors
PR Newswire
10/01 16:10
Heron Therapeutics Appoints Stephen Davis to Board of Directors
PR Newswire
10/01 16:05
Heron Therapeutics Resubmits New Drug Application for Pain Medication to FDA
MT Newswires
10/01 10:04
Heron resubmits NDA for pain med HTX-011
SA Breaking News
10/01 08:56
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Management of Postoperative Pain
PR Newswire
10/01 08:30
Heron Therapeutics to Present at the 2019 Cantor Global Healthcare Conference
PR Newswire
09/25 16:05
Heron's HTX-011 successful in late-stage hernia repair study
SA Breaking News
08/20 10:52
Heron Therapeutics Says Hernia Repair Pain Drug Met Endpoints in Study
MT Newswires
08/20 09:27
Heron Therapeutics Announces Publication of Results from EPOCH 2, a Phase 3 Study of HTX-011 in Patients Undergoing Hernia Repair Surgery
PR Newswire
08/20 08:30
Sector Update: Health Care Stocks Hammered in Market Selloff
MT Newswires
08/05 15:57
Sector Update: Health Care Stocks Sinking in Afternoon Trade
MT Newswires
08/05 14:20
Heron Therapeutics Q2 Results Top Expectations
MT Newswires
08/05 10:00
Heron Therapeutics EPS in-line, beats on revenue
SA Breaking News
08/05 08:34
Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate Updates
PR Newswire
08/05 08:30
MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
08/05 08:15
Final Deadline: (HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead Plaintiff Deadline: August 5, 2019
Globe Newswire
08/02 15:00
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, STG, PVTL and GTT
Globe Newswire
08/02 09:43
Pawar Law Group Reminds Investors of August 5 Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. – HRTX
Globe Newswire
08/02 07:10
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm
Globe Newswire
08/01 14:46
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – HRTX
Globe Newswire
07/31 12:53
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Heron Therapeutics, Box, Beazer Homes, and Cloudera and Encourages Investors to Contact the Firm
Globe Newswire
07/30 18:30
CLASS ACTION UPDATE for MMM, HRTX, CTST and NGHC: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
07/30 11:20
HRTX CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors That Approximately 6 Days Remain To Make A Motion For Lead Plaintiff In A Securities Class Action Lawsuit Against Heron Therapeutics, INC. — HRTX
Globe Newswire
07/30 10:47
ROSEN, A TOP RANKED LAW FIRM, Reminds Heron Therapeutics, Inc. Investors of Important August 5th Deadline in the Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – HRTX
Globe Newswire
07/29 13:32
7-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
07/29 09:10
Heron Therapeutics, Inc. (HRTX), Beazer Homes USA, Inc. (BZH) & Ascena Retail Group, Inc. (ASNA) - Bronstein, Gewirtz & Grossman, LLC Class Action Update
Globe Newswire
07/26 15:00
Zhang Investor Law Reminds Investors of August 5 Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. – HRTX
Globe Newswire
07/26 09:21
HRTX CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors That Approximately 11 Days Remain to Make a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against Heron Therapeutics, Inc. — HRTX
Globe Newswire
07/25 10:21
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against A.O. Smith Corporation, Community Health Systems, Metro Bank, and Heron Therapeutics and Encourages Investors to Contact the Firm
Globe Newswire
07/23 21:30
Federman & Sherwood Reminds Investors of Imminent Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc.
Business Wire
07/23 18:21
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm
Globe Newswire
07/23 17:00
Pawar Law Group Reminds Investors of August 5 Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. – HRTX
Globe Newswire
07/22 17:16
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
07/22 10:10
ROSEN, A TOP RANKED LAW FIRM, Reminds Heron Therapeutics, Inc. Investors of Important August 5th Deadline in the Securities Class Action – HRTX
Globe Newswire
07/20 12:00
Metro Bank PLC (MBNKF), Heron Therapeutics, Inc. (HRTX) & Beazer Homes USA, Inc. (BZH) - Bronstein, Gewirtz & Grossman, LLC Class Action Update
Globe Newswire
07/19 15:00
CLASS ACTION UPDATE for HRTX, PVTL, RMED and ZUO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
07/17 09:14
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Heron Therapeutics, Box, Cloudera, and Mammoth Energy and Encourages Investors to Contact the Firm
Globe Newswire
07/16 21:30
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – HRTX
Globe Newswire
07/16 20:01
HRTX CLASS ACTION DEADLINE: Bernstein Liebhard LLP Reminds Investors That Approximately 2 Weeks Remain to Make a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against Heron Therapeutics, Inc. — HRTX
Globe Newswire
07/16 13:38
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
07/15 11:30
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm
PR Newswire
07/12 16:16
Hecla Mining Company (HL), Community Health Systems, Inc. (CYH) & Heron Therapeutics, Inc. (HRTX) - Bronstein, Gewirtz & Grossman, LLC Class Action Update
Globe Newswire
07/12 15:00
Zhang Investor Law Reminds Investors of Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. – HRTX
Globe Newswire
07/12 11:58
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HRTX, EQT, DBD and INS
Globe Newswire
07/11 09:29
Pawar Law Group Reminds Investors of August 5 Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. – HRTX
Globe Newswire
07/10 16:53
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm
Globe Newswire
07/10 13:45
HRTX Class Action Deadline: Bernstein Liebhard LLP Reminds Investors That Approximately 3 Weeks Remain to Make a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against Heron Therapeutics, Inc. — HRTX
Globe Newswire
07/09 11:36
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – HRTX
Globe Newswire
07/08 18:25
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
07/08 11:25
CLASS ACTION UPDATE for HRTX, STG, PYX and ZUO: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
07/08 09:36
Intersect ENT, Inc. (XENT), Community Health Systems, Inc. (CYH) & Heron Therapeutics, Inc. (HRTX) - Bronstein, Gewirtz & Grossman, LLC Class Action Reminder
Globe Newswire
07/05 15:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Heron Therapeutics, Box, Cloudera, and Mammoth Energy and Encourages Investors to Contact the Firm
Globe Newswire
07/02 21:30
SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – HRTX
Globe Newswire
07/01 15:58
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
07/01 14:20
HRTX Class Action Deadline: Bernstein Liebhard LLP Reminds Investors That Approximately 5 Weeks Remain to Make a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against Heron Therapeutics, Inc. — HRTX
Globe Newswire
06/28 16:40
Game-changer of a call on Heron Therapeutics?
SA Breaking News
06/28 09:59
CLASS ACTION UPDATE for AOS, HRTX, BOX and FDX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Globe Newswire
06/27 16:05
UPCOMING DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Business Wire
06/27 14:28
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Heron Therapeutics, Box, Cloudera, and Mammoth Energy and Encourages Investors to Contact the Firm
Globe Newswire
06/26 21:30
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – HRTX
Globe Newswire
06/26 16:33
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm
Globe Newswire
06/26 16:01
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
06/25 11:20
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM: Announces Filing of Securities Class Action Lawsuit Against Heron Therapeutics, Inc. – HRTX
Globe Newswire
06/22 10:15
Pawar Law Group Reminds Investors of Deadline in Securities Class Action Lawsuit Against Heron Therapeutics, Inc. – HRTX
Globe Newswire
06/21 16:11
SHAREHOLDER ALERT: PSMT INVVY MOMO HRTX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Globe Newswire
06/19 09:37
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Indivior, Heron Therapeutics, Mammoth Energy, and ChinaCache and Encourages Investors to Contact the Firm
Globe Newswire
06/18 21:30
TOP RANKED ROSEN LAW FIRM: Announces Filing of Securities Class Action Lawsuit Against Heron Therapeutics, Inc.; Encourages Investors with Losses in Excess of $100K to Contact the Firm – HRTX
Globe Newswire
06/18 20:00
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – HRTX
Globe Newswire
06/18 16:48
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm
Globe Newswire
06/18 14:47
HRTX Class Action Deadline: Bernstein Liebhard LLP Reminds Investors That Approximately 7 Weeks Remain to Make a Motion for Lead Plaintiff in a Securities Class Action Lawsuit Against Heron Therapeutics, Inc. — HRTX
Globe Newswire
06/18 12:59
INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
06/18 11:00
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Heron Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - HRTX
PR Newswire
06/17 20:39
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of APYX, NOK, HRTX and TUSK
Globe Newswire
06/17 09:10
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Heron Therapeutics, Inc.
Business Wire
06/14 16:36
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Heron Therapeutics, Inc. – HRTX
Globe Newswire
06/14 15:44
Community Health Systems, Inc. (CYH) & Heron Therapeutics, Inc. (HRTX) - Bronstein, Gewirtz & Grossman, LLC Class Action Update
Globe Newswire
06/14 15:00
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Heron Therapeutics, Inc.
Business Wire
06/13 18:18
Heron Therapeutics to Present at 2019 JMP Securities Life Sciences Conference
PR Newswire
06/13 16:05
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Heron Therapeutics, Inc. - HRTX
PR Newswire
06/12 16:45
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm
Globe Newswire
06/12 16:29
INVESTOR ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
06/12 12:46
HERON THERAPEUTICS, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for Southern District of California against Heron Therapeutics, Inc.
Globe Newswire
06/10 16:12
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Heron Therapeutics, Inc. Investors
Business Wire
06/07 17:27
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Heron Therapeutics, Inc. Investors (HRTX)
Business Wire
06/06 18:23
INVESTOR ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Heron Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Globe Newswire
06/06 13:33